<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02538731</url>
  </required_header>
  <id_info>
    <org_study_id>sdqfs001</org_study_id>
    <nct_id>NCT02538731</nct_id>
  </id_info>
  <brief_title>Laser Lithotripsy for Difficult Large Bile Duct Stones</brief_title>
  <official_title>Randomized Trial of Spyglass Guided Laser Lithotripsy Versus Dilation-Assisted Stone Extraction for the Endoscopic Removal of Difficult Large Bile Duct Stones</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shandong Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shandong Provincial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Very large bile duct stones are difficult to remove. Dilation-assisted stone extraction, also&#xD;
      termed small endoscopic sphincterotomy plus endoscopic papillary large balloon dilatation, is&#xD;
      safe and effective technique for the treatment of large CBD stones. However, in approximately&#xD;
      5-10% of patients, the removal of large bile duct stones may be difficult. For this selected&#xD;
      group of patients for whom all conventional endoscopic stone treatment devices have failed,&#xD;
      laser lithotripsy technology has provided an approach to the fragmentation of difficult bile&#xD;
      duct stones.&#xD;
&#xD;
      A single-operator cholangioscopy (SOC) system (SpyGlass Direct Visualization System, Boston&#xD;
      Scientific Corp., Natick, MA, USA) has overcome most of the conventional cholangioscopy&#xD;
      limitations. The investigators aimed to evaluate the efficacy and safety of Spyglass-guided&#xD;
      laser lithotripsy for difficult CBD stones not amenable to conventional dilation-assisted&#xD;
      stone extraction therapy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose Very large bile duct stones are difficult to remove.Dilation-assisted stone&#xD;
      extraction, also termed small endoscopic sphincterotomy plus endoscopic papillary large&#xD;
      balloon dilatation, is safe and effective technique for the treatment of large CBD&#xD;
      stones.However, in approximately 5-10% of patients, the removal of large bile duct stones may&#xD;
      be difficult. For this selected group of patients for whom all conventional endoscopic stone&#xD;
      treatment devices have failed, laser lithotripsy technology has provided an approach to the&#xD;
      fragmentation of difficult bile duct stones.&#xD;
&#xD;
      A single-operator cholangioscopy (SOC) system(SpyGlass Direct Visualization System, Boston&#xD;
      Scientific Corp., Natick, MA, USA) has overcome most of the conventional cholangioscopy&#xD;
      limitations.We aimed to evaluate the efficacy and safety of Spyglass-guided laser lithotripsy&#xD;
      for difficult CBD stones not amenable to conventional dilation-assisted stone extraction&#xD;
      therapy.&#xD;
&#xD;
      Study Type: Interventional Study Design: Allocation: Randomized Endpoint Classification:&#xD;
      Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject)&#xD;
      Primary Purpose: Treatment Official Title: Randomized Trial of Spyglass Guided Laser&#xD;
      Lithotripsy Versus Dilation-Assisted Stone Extraction for the Endoscopic Removal of Difficult&#xD;
      Large Bile Duct Stones&#xD;
&#xD;
      Primary Outcome Measures:&#xD;
&#xD;
      • Bile Duct Stone Clearance Confirmation that no further stones remain in the bile duct of&#xD;
      the patient by cholangiography. Additionally, serum laboratory abnormalities in AST, ALT,&#xD;
      Alkaline Phophatase, or bilirubin, or epigastric abdominal pain attributable to bile duct&#xD;
      stones.&#xD;
&#xD;
      Secondary Outcome Measures:&#xD;
&#xD;
        -  Number of ERCP&#xD;
&#xD;
        -  The number of ERCP procedures required to complete clearance of bile duct stones.&#xD;
&#xD;
        -  Total Procedure Time&#xD;
&#xD;
        -  The total time in minutes for all the ERCP procedures required for stone removal.&#xD;
&#xD;
        -  Estimated Procedure Cost&#xD;
&#xD;
        -  The cost of patient management for bile duct stones based on the cost of the procedure,&#xD;
           hospitalization, and associated costs of complications of cholangitis, pancreatitis,&#xD;
           perforation, and bleeding.&#xD;
&#xD;
        -  Cholangitis Cholangitis after or between ERCP procedures will be defined as a&#xD;
           presentation with epigastric abdominal pain, temperature greater than 38.5 Celsius&#xD;
           accompanied by either laboratory abnormalities of the AST, ALT, Alkaline Phosphatase, or&#xD;
           Bilirubin or abnormal imaging of the biliary tree on ultrasound,computed tomography&#xD;
           scan, or magnetic resonance cholangiopancreatography.&#xD;
&#xD;
        -  Pancreatitis&#xD;
&#xD;
        -  Pancreatitis following or between ERCP procedures will be defined as the onset of&#xD;
           epigastric abdominal pain and either amylase or lipase greater than 3 times the upper&#xD;
           limit of normal or findings on ultrasound, computed tomography scan, or magnetic&#xD;
           resonance cholangiopancreatography suggestive of pancreatic inflammation.&#xD;
&#xD;
        -  Bleeding&#xD;
&#xD;
        -  Bleeding attributable to stone therapy will be defined as a drop in hemoglobin by more&#xD;
           than 1 gm/dl following or between ERCP procedures with no other cause identified on&#xD;
           standard clinical evaluation.&#xD;
&#xD;
      Eligibility&#xD;
&#xD;
      Ages Eligible for Study: 18 Years and older Genders Eligible for Study: Both Accepts Healthy&#xD;
      Volunteers: No Criteria&#xD;
&#xD;
      Inclusion Criteria:&#xD;
&#xD;
      • Bile duct stone &gt;1.5cm demonstrated on ultrasound, computed tomography, or magnetic&#xD;
      resonance imaging&#xD;
&#xD;
      Exclusion Criteria:&#xD;
&#xD;
        -  Biliary, gallbladder or pancreatic malignancy&#xD;
&#xD;
        -  Pregnant&#xD;
&#xD;
        -  Prior biliary diversion surgery&#xD;
&#xD;
        -  Under age 18&#xD;
&#xD;
        -  Unable to give informed consent&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bile Duct Stone Clearance</measure>
    <time_frame>1 hour</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Sphincterotomy, Endoscopic</condition>
  <condition>Cholangiopancreatography, Endoscopic Retrograde</condition>
  <condition>Lithotripsy, Laser</condition>
  <arm_group>
    <arm_group_label>Dilation-assisted group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Dilation-assisted group:Dilation-assisted stone extraction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>laser lithotripsy group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>laser lithotripsy group:laser lithotripsy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>dilation-assisted stone extraction</intervention_name>
    <arm_group_label>Dilation-assisted group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spyglass Guided Laser Lithotrips</intervention_name>
    <arm_group_label>laser lithotripsy group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Bile duct stone &gt;1.5cm demonstrated on ultrasound, computed tomography, or magnetic&#xD;
             resonance imaging&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Biliary, gallbladder or pancreatic malignancy&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  Prior biliary diversion surgery&#xD;
&#xD;
          -  Under age 18&#xD;
&#xD;
          -  Unable to give informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2015</verification_date>
  <study_first_submitted>August 30, 2015</study_first_submitted>
  <study_first_submitted_qc>September 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 2, 2015</study_first_posted>
  <last_update_submitted>September 1, 2015</last_update_submitted>
  <last_update_submitted_qc>September 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shandong Provincial Hospital</investigator_affiliation>
    <investigator_full_name>guodong li</investigator_full_name>
    <investigator_title>guodong li</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

